|
||||||||||||||||||||||
Explore All PharmaNews.eu RSS Channels
RSS is a simple way for you to keep up to date with our latest news. Instead of looking around various web sites manually, you can use the RSS service to get continuous information about newly posted material on the PharmaNews.eu website. RSS (which stands for Rich document format Site
Advertise with PharmaNews.eu
Alternatively, you might target PharmaNews.eu for advertising through your Google AdWords account, and let Google keep track of click-throughs, and budget your daily allotments...
 Pfizer and Medivation Announce Results From Two Phase 3 Studies in DimebonPfizer Inc. (NYSE: PFE) and Medivation, Inc. (NASDAQ: MDVN) announced results from two Phase 3 trials of the i... |
 Nycomed on track in 2009 with strong growth in Key ProductsNycomed was on track in 2009, with strong growth in Key Products and most emerging markets. Pantoprazole sales... |
 Bayer Successful in a Difficult Environment2009 was operationally one of the strongest years for the Bayer Group. "We were successful in a difficult envi... |
 Phase III study of Avastin in advanced stomach cancer did not meet primary endpointRoche (SIX: RO, ROG; OTCQX: RHHBY) announced the topline results from a global phase III trial investigating t... |
|
More in: Pfizer, GlaxoSmithKline, Bayer, AstraZeneca, Novo Nordisk, Novartis, Roche, Sanofi-aventis, Boehringer Ingelheim, Merck KGaA, Abbott, Nycomed, Schering-Plough, Merck, Genzyme, Lilly, Bristol-Myers Squibb, Shire, Amgen |
|
Research & Development
Novel Drug for Chronic Management of Hyperuricemia in Gout PatientsTeijin Pharma Limited announced the European launch of TMX-67 (febuxostat), a novel drug discovered by Teijin Pharma for the treatment... |
Synthon completes acquisition of Nafar LaboratoriosSynthon announces its acquisition of Nafar Laboratorios - a developer, manufacturer and distributor of generic drugs to the Mexican market.... |
MitoTarget Launches New Online Resource for Physicians and Sufferers from Rare Illness ALSTrophos, the pharmaceutical company specialising in therapies for orphan diseases including ALS (also known as Lou Gehrig's disease), announces, on... |
EU-funded researchers sequence human gut microbe genomeEU-funded researchers have sequenced the genome of the community of microbes that lives in our guts. The study sheds new... |
|
More in: Research & Development |
|
Conferences & Events
Web Innovators, Pharma, Insurance and Government Converge to Speak at Health 2.0 Europe6-7 April 2010, Paris, France. Health 2.0 Europe, a conference dedicated to how Web 2.0 and social media are transforming healthcare systems in Europe, has finalized its agenda and speaker... |
analytica Conference 2010: Trendsetter in analytical chemistry and bioanalysisMore than 1,000 international exhibitors will gather in Munich this year for analytica, the world's largest trade fair for analysis and laboratory technology in chemistry, biochemistry, food chemistry, clinical chemistry... |
Job Day analytica 2010: Platform and source of inspiration for jobs and careersAs in the past, the leading international trade fair analytica 2010 will spend an entire day being a source of inspiration for everyone who is planning to embark on a... |
Dialog Between Life-Science Companies and Investorsanalytica 2010 will bring new and experienced life-science entrepreneurs together with investors for the second Finance Day on Friday, March 26, 2010. Organized by GoingPublic Media AG, the information event... |
Final agenda and Sponsorship deadline for Health 2.0 EuropeHealth 2.0 Europe will be a unique conference, featuring the three integral components of Health 2.0 in a unique format where leading examples of Health 2.0 in North America will... |
|
More in: Conferences & Events
|
EC Pharmaceuticals
EC tops a billion Euros invested in the fight against AIDS Not too far from World AIDS Day, the European Commission can announce that it has invested over one billion Euros in the fight against AIDS, Tuberculosis and Malaria. As a... |
European Commission tops a billion Euros invested in the fight against the global AIDS epidemicThe European Commission has invested over one billion Euros in the fight against AIDS, Tuberculosis and Malaria. As a founding member of the Global Fund to Fight AIDS, Tuberculosis and... |
European Partnership for Action against CancerAt the end of September month, in Brussels, over 300 cancer organisations, patients and cancer survivors, health professionals, researchers, health authorities and health ministers gather to mark the official launch... |
Commission calls on EU Member States to join forces against Alzheimer's diseaseOn 22 July the European Commission called on EU Member States to pool their resources and better coordinate research efforts to combat Alzheimer's and other neurodegenerative diseases. The proposals adopted... |
Public call for expressions of interest for Commission appointeesThis public call for expressions of interest relates to the appointment by the European Commission of members representing patients' organisations at the Committee for Orphan Medicinal Products of the European... |
|
More in: European Commission
|
EMEA News
European Medicines Agency advises of risk of fever in young children following vaccination with Pandemrix The European Medicines Agency is warning that young children may experience fever after their second dose of the pandemic influenza vaccine Pandemrix. Prescribers and parents should monitor the temperature of... |
EMEA makes recommendations to minimise risk of nephrogenic systemic fibrosis with gadolinium-containing contrast agentsThe European Medicines Agency (EMEA) has adopted a set of recommendations aimed at minimising the risk of nephrogenic systemic fibrosis (NSF) with gadolinium-containing contrast agents in patients at risk of... |
European Medicines Agency 2009 mid-year report shows it is still on target, despite influenza pandemic activitiesThe European Medicines Agency is performing on target despite the increase of activities relating to the influenza pandemic. This was the message given by the Agency's Executive Director, Thomas Lönngren,... |
European Medicines Agency implements internal reorganisationThe European Medicines Agency has begun implementing a series of changes to its internal organisation aimed at improving the functioning of the Agency and the way in which it delivers... |
|
More in: EMEA
|
Industry News
Abbott | AstraZeneca | Bayer | Boehringer Ingelheim | Bristol-Myers Squibb | Genzyme | GlaxoSmithKline | Lilly | Merck | Merck KGaA | Novartis | Novo Nordisk | Nycomed | Pfizer | Roche | Sanofi-aventis | Schering-Plough | Shire | ...Suggest/Propose your Company News.
